Marico (MARICO.NS) traded down -1.1 % during a 24 hours period ending at 08:50 PM Central Europe on Monday 26th. One Marico stock can currently be bought for about INR 775.15 on popular exchanges. Current supply of Marico stocks is 1.3 bn. Marico has a current market capitalization of INR 993.7 bn and approximately INR 1.4 bn worth of Marico was traded on exchanges in the last 24 hours. Since last month end, Marico has traded -7.04 % down. Simple moving average of last 200 days is at INR 801.53. The highest price of past 52 weeks was recorded at INR 889.1 on 07/30/2026. 52 weeks low was at INR 705.8 on 11/07/2025.
Here is how related stocks have performed in the past 24 hours:
Siemens (SIEMENS.NS) traded down -4.02 % and now trades at INR 3,278.8. Siemens has a market capitalisation of INR 1.2 trillions. Current price/earnings ratio for Siemens is 83.96.
Zydus Lifesciences (ZYDUSLIFE.NS) traded down -0.49 % and now trades at INR 1,160.4. Current market capitalisation for Zydus Lifesciences is INR 1.1 trillions. Zydus Lifesciences has a current price to earnings ratio of 24.9. Nomura has upgraded its valuation for Zydus Lifesciences, lifting the target price to Rs 1,450 while maintaining a “Buy” recommendation. The brokerage cites the company’s aggressive expansion into new business lines, including MedTech, biologics contract manufacturing, and specialty brands in the United States and abroad, as key growth drivers. It notes that Zydus is investing heavily in capital expenditures and acquisitions, with a significant portion of spending aimed at higher‑value, “sticky” segments. Despite the increased outlays, Nomura argues the firm’s solid base business and strong performance in India and other international markets are cushioning the impact on profitability. The analyst highlights the company’s diverse pipeline—including biosimilars, vaccines, and cell and gene therapies—as a source of future upside, while projecting a stable EBITDA margin in the coming years. The revised target price reflects a more modest earnings multiple, reflecting the company’s continued emphasis on long‑term strategic positioning.
Indian Hotels (INDHOTEL.NS) traded down -0.07 % and now trades at INR 795.5. Indian Hotels has a market capitalisation of INR 1.1 trillions. Current price/earnings ratio for Indian Hotels is 53.4.
Hdfc Life Insurance (HDFCLIFE.NS) traded down -0.87 % and now trades at INR 519. Hdfc Life Insurance has a market capitalisation of INR 1.1 trillions. Current price/earnings ratio for Hdfc Life Insurance is 56.86. HDFC Life Insurance Co Ltd is preparing for the forthcoming overhaul of financial reporting standards under Ind AS 118. The company’s audit committee, led by its chair, has begun reviewing the potential impact of new classification rules for income and expenses, as well as the revised operating‑profit reporting framework. Discussions focus on how the changes may affect internal control systems and the presentation of performance metrics. While the Ministry of Corporate Affairs has yet to issue final guidelines, HDFC Life is engaging in preparatory work to map existing financial‑statement lines to the proposed categories and to assess the data and system adjustments that may be required. The transition, anticipated to align Indian practice more closely with international standards, is expected to influence how investors interpret the company’s financial statements once the new requirements are implemented.
Polycab India (POLYCAB.NS) traded down -3.01 % and now trades at INR 7,739. Current market capitalisation for Polycab India is INR 1.1 trillions. Current price/earnings ratio for Polycab India is 37.16.